尤瑞克林对大面积脑梗塞患者神经功能预后的影响

Urinary Kallidinogenase on a Large Area of Cerebral Infarction Patients with Neurologic Prognosis

目的观察尤瑞克林对大面积脑梗塞的治疗效果。方法将大面积脑梗塞患者随机分为两组，对照组给予常规治疗治疗组在常规治疗的基础上加用尤瑞克林1次／d，连用14d；治疗前后定期对患者进行美国国立卫生研究院卒中评分量表（NIHSS）Barthel指数03I）进行评分，14d后对两组进行评分比较和临床疗效评定。结果治疗前两组NIHSS和BI评分无显著差异，治疗后14d，治疗组NIHSS和BI评分较治疗前显著增加。其中1例出现腹痛，1例出现发热，停药后均缓解。结论尤瑞克林治疗大面积脑梗塞患者安全、有效，减少致残率，可改善患者的生活质量。

Objective to observe the effect of Urinary Kallidinogenase with large cerebral infarction treatment. Methods large area cerebral infarction patients were randomly divided into two groups： control group give routine therapy treatment group based on routine treatment combined with a day＇s Urinary Kallidinogenase once, forl4 days; Before and after treatment for patients on a regular basis of the national institutes of health stroke scale （NIHSS） scores and scores Barthel index （BI） rating, 14 days of two groups are compared and clinical curative effect evaluation score. Results two groups before treatment NIHSS and BI score no significant differences after treatment for 14 days, the treatment group NIHSS scores before treatment and BI is significantly increased. One of those appear abdominal pain, fever occurred, stopping medication are easing. Conclusion Kallidinogenase treatment of large cerebral infarction patient safety and effective, and reduce the morbidity, can improve the patient＇s quality of lifeo